Page last updated: 2024-09-02

ramosetron and pumosetrag

ramosetron has been researched along with pumosetrag in 1 studies

Compound Research Comparison

Studies
(ramosetron)
Trials
(ramosetron)
Recent Studies (post-2010)
(ramosetron)
Studies
(pumosetrag)
Trials
(pumosetrag)
Recent Studies (post-2010) (pumosetrag)
1949483843

Protein Interaction Comparison

ProteinTaxonomyramosetron (IC50)pumosetrag (IC50)
Cytochrome P450 1A2Homo sapiens (human)10
Cytochrome P450 3A4Homo sapiens (human)9.3
Cytochrome P450 2D6Homo sapiens (human)10
Cytochrome P450 2C9 Homo sapiens (human)10
Cytochrome P450 2B6Homo sapiens (human)10
Cytochrome P450 2C19Homo sapiens (human)10

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, NM; Brady, CA; Butler, AS; Choo, SH; Cioffi, CL; Cohen, ML; Dobritsa, S; Earley, WG; Fitzpatrick, K; Guo, C; Guzzo, PR; Hassler, C; Manning, DD; Masih, L; Naginskaya, J; Ryan, KN; Sikkander, MI; Usyatinsky, A; Wierschke, JD; Zhang, Z1

Other Studies

1 other study(ies) available for ramosetron and pumosetrag

ArticleYear
Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.
    Bioorganic & medicinal chemistry letters, 2011, Jan-01, Volume: 21, Issue:1

    Topics: Animals; Cell Line; Disease Models, Animal; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Mice; Microsomes, Liver; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Agonists

2011